Literature DB >> 9822275

Anti-alpha-gliadin antibodies (AGA) in the serum of coeliac children and controls recognize an identical collection of linear epitopes of alpha-gliadin.

M ten Dam1, Y Van De Wal, M L Mearin, Y Kooy, S Peña, J W Drijfhout, F Koning, M Van Tol.   

Abstract

Anti-gliadin antibodies can be found in the serum of patients with overt and subclinical coeliac disease, but also in that of some controls. The aim of the present study was to identify the linear epitopes of the alpha-gliadin molecule to which the humoral response is directed. Therefore, the IgG and IgA antibody reactivity against an overlapping set of synthetic peptides covering the entire sequence of alpha-gliadin was measured in the sera from patients with coeliac disease, from controls with elevated titres of anti-gliadin antibodies and from healthy children using an ELISA technique. The antibodies mainly recognize peptides derived from the N-terminal region of alpha-gliadin, containing the motif QPFXXQXPY. Reactivity was also detected against two other synthetic peptides, which do not contain this motif and represent a sequence encoded further to the C-terminal region of alpha-gliadin. Anti-gliadin antibodies in sera from patients with coeliac disease and from controls recognize the same linear epitopes. Thus, serological investigation of the specificity of these antibodies using a peptide ELISA does not allow discrimination between patients and controls.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822275      PMCID: PMC1905116          DOI: 10.1046/j.1365-2249.1998.00722.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

Review 1.  Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition.

Authors: 
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

2.  In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease.

Authors:  G de Ritis; S Auricchio; H W Jones; E J Lew; J E Bernardin; D D Kasarda
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

3.  Gliadin and reticulin antibodies in childhood coeliac disease.

Authors:  D J Unsworth; J A Walker-Smith; E J Holborow
Journal:  Lancet       Date:  1983-04-16       Impact factor: 79.321

4.  IgA antigliadin antibodies in celiac and inflammatory bowel disease.

Authors:  C R Koninckx; J P Giliams; I Polanco; A S Peña
Journal:  J Pediatr Gastroenterol Nutr       Date:  1984-11       Impact factor: 2.839

5.  Normal small bowel biopsy followed by coeliac disease.

Authors:  M Mäki; K Holm; S Koskimies; O Hällström; J K Visakorpi
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

6.  Evolution and heterogeneity of the alpha-/beta-type and gamma-type gliadin DNA sequences.

Authors:  T W Okita; V Cheesbrough; C D Reeves
Journal:  J Biol Chem       Date:  1985-07-05       Impact factor: 5.157

7.  Coeliac disease. II. The presence in wheat of a factor having a deleterious effect in cases of coeliac disease.

Authors:  W K DICKE; H A WEIJERS; J H VAN DE KAMER
Journal:  Acta Paediatr       Date:  1953-01       Impact factor: 2.299

8.  Nucleic acid (cDNA) and amino acid sequences of alpha-type gliadins from wheat (Triticum aestivum).

Authors:  D D Kasarda; T W Okita; J E Bernardin; P A Baecker; C C Nimmo; E J Lew; M D Dietler; F C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

9.  Wheat grains: a substrate for the determination of gluten antibodies in serum of gluten-sensitive patients.

Authors:  K P Eterman; W T Hekkens; A S Pena; P H Lems-van Kan; T E Feltkamp
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

10.  A family study of coeliac disease.

Authors:  L Stenhammar; A Brandt; J Wågermark
Journal:  Acta Paediatr Scand       Date:  1982-07
View more
  6 in total

1.  Interplay between genetics and the environment in the development of celiac disease: perspectives for a healthy life.

Authors:  G K Papadopoulos; C Wijmenga; F Koning
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

2.  B cell epitopes of gliadin.

Authors:  A A Osman; T Günnel; A Dietl; H H Uhlig; M Amin; B Fleckenstein; T Richter; T Mothes
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

3.  Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A.

Authors:  T Rauhavirta; S-W Qiao; Z Jiang; E Myrsky; J Loponen; I R Korponay-Szabó; H Salovaara; J A Garcia-Horsman; J Venäläinen; P T Männistö; R Collighan; A Mongeot; M Griffin; M Mäki; K Kaukinen; K Lindfors
Journal:  Clin Exp Immunol       Date:  2011-01-14       Impact factor: 4.330

4.  IgA antibodies of coeliac disease patients recognise a dominant T cell epitope of A-gliadin.

Authors:  E A L Bateman; B L Ferry; A Hall; S A Misbah; R Anderson; P Kelleher
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

Review 5.  Assessing of Celiac Disease and Nonceliac Gluten Sensitivity.

Authors:  N Ontiveros; M Y Hardy; F Cabrera-Chavez
Journal:  Gastroenterol Res Pract       Date:  2015-04-29       Impact factor: 2.260

6.  Determination of B-Cell Epitopes in Patients with Celiac Disease: Peptide Microarrays.

Authors:  Rok Seon Choung; Eric V Marietta; Carol T Van Dyke; Tricia L Brantner; John Rajasekaran; Pankaj J Pasricha; Tianhao Wang; Kang Bei; Karthik Krishna; Hari K Krishnamurthy; Melissa R Snyder; Vasanth Jayaraman; Joseph A Murray
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.